Brii Biosciences Ltd to Discuss VBI Deal and Corporate Update Call Transcript
(foreign language) Good morning, and good evening, everyone. Thank you for your interest in Brii Bio, and welcome to participate in our business update call. I would like to remind you that remarks made on today's call may include forward-looking statements. The company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, further events or otherwise.
This is Chris, Company IR Director. I'm joined today by Dr. Zhi Hong, our Founder and CEO; Dr. Ankang Li, our Chief Strategy and Financial Officer; Dr. David Margolis, Chief Medical Officer; Dr. Susannah Cantrell, Chief Business Officer; Dr. Qing Zhu, Head of China R&D; Dr. Ellee de Groot, Chief Technology Officer; and Mr. Rico Liang, Greater China General Manager.
A few hours ago, we just announced the VBI transaction. So join me today, our senior management team would like to share more details regarding on the deal. After our presentation, we will open the call for Q&A. (foreign language) Welcome your questions conducted in Mandarin as well. So I would like to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
